Tuberculosis can present with a variety of symptoms, which often develop gradually. The most common symptoms include a persistent cough lasting more than three weeks, chest pain, and coughing up blood or sputum. Other systemic symptoms may include fever, night sweats, fatigue, and unintended weight loss. In cases where TB affects organs other than the lungs, symptoms can vary widely depending on the site of infection.

Diagnosing TB involves a combination of clinical evaluation, imaging, and laboratory tests. A chest X-ray is often used to identify lung abnormalities. The definitive diagnosis is made by detecting Mycobacterium tuberculosis in a sputum sample, which can be done through a sputum smear microscopy or culture. Molecular tests, such as the nucleic acid amplification test (NAAT), are also used for rapid and accurate detection. In some cases, a tuberculin skin test or interferon-gamma release assays (IGRAs) may be used to identify latent TB infection.

The treatment of TB involves a regimen of antibiotics taken over a period of at least six months. The standard treatment includes a combination of four first-line drugs: isoniazid, rifampicin, ethambutol, and pyrazinamide. Adherence to the full course of treatment is crucial to prevent the development of drug-resistant TB. In cases of multidrug-resistant TB (MDR-TB), treatment may require second-line drugs and a longer duration.

With appropriate treatment, the prognosis for TB is generally good, and most patients can be cured. However, untreated TB can be fatal. The prognosis may be poorer in cases of drug-resistant TB or in patients with weakened immune systems, such as those with HIV/AIDS. Early detection and adherence to treatment are key factors in improving outcomes.

Mycobacterium tuberculosis is a slow-growing bacterium that primarily infects the lungs. It is transmitted from person to person through the air when an infected individual coughs, sneezes, or speaks. Not everyone exposed to the bacterium will develop active TB; some may develop a latent infection, which can become active if the immune system becomes compromised.

TB is a global health issue, with millions of new cases reported each year. It is most prevalent in regions with high rates of HIV, poverty, and limited access to healthcare. The World Health Organization (WHO) has identified TB as one of the top 10 causes of death worldwide, with the highest burden in Africa and Southeast Asia.

Once inhaled, Mycobacterium tuberculosis can reach the alveoli in the lungs, where it is engulfed by immune cells called macrophages. The bacteria can survive and multiply within these cells, leading to the formation of granulomas, which are clusters of immune cells that attempt to contain the infection. If the immune system fails to control the bacteria, the infection can spread, causing active TB disease.

Preventing TB involves several strategies, including vaccination, early detection, and treatment of latent TB infection. The Bacillus Calmette-Guérin (BCG) vaccine is used in many countries to protect against severe forms of TB in children. Public health measures, such as improving living conditions and reducing overcrowding, also play a crucial role in prevention.

Mycobacterium tuberculosis is the bacterium that causes tuberculosis, a serious infectious disease primarily affecting the lungs. It is spread through the air and can be prevented and treated with appropriate measures. Early diagnosis and adherence to treatment are essential for controlling the disease and preventing its spread.

If you suspect you have been exposed to TB or are experiencing symptoms such as a persistent cough, fever, or night sweats, it is important to seek medical evaluation. TB is a treatable condition, and early intervention can lead to successful outcomes. Remember to follow your healthcare provider's instructions and complete the full course of treatment if diagnosed with TB.